Jim Simons Geo Vax Labs, Inc. Transaction History

Renaissance Technologies LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$0.3 - $0.57 $8,610 - $16,358	28,700 New	28,700 $10,000
Q4 2022 Feb 13, 2023	SELL	$0.55 - $17.1 $349,285 - $10.9 Million	-635,065 Reduced 60.74%	410,461 $259,000
Q3 2022 Nov 14, 2022	BUY	$0.4 - $58.5 $257,558 - $37.7 Million	643,897 Added 160.32%	1,045,526 $1.14 Million
Q2 2022 Aug 12, 2022	BUY	$9.29 - $34.8 $3.73 Million - $14 Million	401,629 New	401,629 $333,000

Ticker GOVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,744,000
Market Cap $69.8M
Description
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhag...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.